Event Title

Concerning the Ethical Treatment of Human Subjects in Pharmaceutical Clinical Trials in the Developing World

Location

CSU 203

Start Date

9-4-2012 1:00 PM

End Date

9-4-2012 2:00 PM

Student's Major

Philosophy

Student's College

Arts and Humanities

Mentor's Name

Brandon Cooke

Mentor's Department

Philosophy

Mentor's College

Arts and Humanities

Description

As an Open Studies major, I have taken courses in biology, philosophy, and international relations, which is a challenging combination that allows me to study medical ethics on an international scale. I am completing a capstone project that focuses on the care and treatment of human test subjects in drug trials, especially those sponsored by American pharmaceutical companies that take place in international settings. To assist with this, I have read the book White Coat, Black Hat: Adventures on the Dark Side of Medicine by Dr. Carl Elliott and studied different ethical theories, in particular, Immanuel Kant’s categorical imperative, which is a moral theory that requires respect for the autonomy of persons. Pharmaceutical companies that sponsor the studies are concerned with the speed at which a drug can be pushed through the development process at low cost, and it is because of this that ethical treatment of test subjects tends to fall by the wayside, even if the study boasts that the trial helps those that might not otherwise receive medical care. This is arguably a violation of the categorical imperative, and it puts those of us who benefit from such trials in league with the sponsors. I will present cases of recent overseas clinical trials to offer specific ethical and practical recommendations for pharmaceutical companies, and for patients who accept treatments developed through the exploitation of other persons.

This document is currently not available here.

Share

COinS
 
Apr 9th, 1:00 PM Apr 9th, 2:00 PM

Concerning the Ethical Treatment of Human Subjects in Pharmaceutical Clinical Trials in the Developing World

CSU 203

As an Open Studies major, I have taken courses in biology, philosophy, and international relations, which is a challenging combination that allows me to study medical ethics on an international scale. I am completing a capstone project that focuses on the care and treatment of human test subjects in drug trials, especially those sponsored by American pharmaceutical companies that take place in international settings. To assist with this, I have read the book White Coat, Black Hat: Adventures on the Dark Side of Medicine by Dr. Carl Elliott and studied different ethical theories, in particular, Immanuel Kant’s categorical imperative, which is a moral theory that requires respect for the autonomy of persons. Pharmaceutical companies that sponsor the studies are concerned with the speed at which a drug can be pushed through the development process at low cost, and it is because of this that ethical treatment of test subjects tends to fall by the wayside, even if the study boasts that the trial helps those that might not otherwise receive medical care. This is arguably a violation of the categorical imperative, and it puts those of us who benefit from such trials in league with the sponsors. I will present cases of recent overseas clinical trials to offer specific ethical and practical recommendations for pharmaceutical companies, and for patients who accept treatments developed through the exploitation of other persons.

Recommended Citation

Stark, Anna. "Concerning the Ethical Treatment of Human Subjects in Pharmaceutical Clinical Trials in the Developing World." Undergraduate Research Symposium, Mankato, MN, April 9, 2012.
http://cornerstone.lib.mnsu.edu/urs/2012/oral-session-08/4